Warren Center for Neuroscience Drug Discovery Employee Directory
Research ServicesTennessee, United States51-200 Employees
Located in Franklin, Tennessee, the Warren Center for Neuroscience Drug Discovery operates as part of Vanderbilt University within the research services field. It aims to extend basic neuroscience research into tangible drug discovery projects that could advance toward patient-focused clinical testing. The center targets major brain disorders, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, and autism, seeking to convert laboratory findings into new therapeutic strategies. By integrating drug-discovery activities with academic science, it seeks to produce patentable and clinically relevant drug candidates for trials. The center collaborates with other researchers and industry partners to develop new treatments for brain-related conditions, emphasizing small molecule therapeutics. A notable development in its recent activity is a 2022 collaboration with Prothena to pursue small molecule therapeutics for Alzheimer's disease in individuals with Down syndrome.